[{"type": "title", "data": "COVID-19 Sotrovimab (Version 2.32)"}, {"type": "category", "data": "Patient Care"}, {"type": "note", "data": "Refer to latest BC CDC COVID-19 Therapeutics Committee Guidelines for most up-to-date criteria."}, {"type": "note", "data": "Patients unable to receive nirmatrelvir-ritonavir (Paxlovid) or remdesivir, sotrovimab is considered a third line option in confirmed, mildly-ill COVID-19 (e.g. no supplemental oxygen) who are:-outpatients or hospitalized for non-COVID-19 related reasons-within 7 days of symptom onset *AND* one of the following:-inadequate immune response to COVID-19 vaccine or high-risk conditions regardless of vaccine status-unimmunized and either 50 years or older or have three or more chronic conditions (listed below)-partially immunized and 50 years or older with three or more chronic conditions (listed below)-partially immunized and 70 years or older with one or more chronic conditions (listed below)-self-identify as Indigenous (e.g. First Nations [including status and non-status], Inuit or Metis)&quot;"}, {"type": "note", "data": "Chronic conditions that increase risk for developing severe COVID-19 related complications:-hypertension/heart disease-stroke-chronic kidney disease-COPD-diabetes-neurological conditions-obesity (BMI greater than 30)-smoking"}, {"type": "note", "data": "Do NOT use sotrovimab if:-symptoms consistent with severe COVID-19 defined by shortness of breath at rest or respiratory distress and requiring supplemental oxygen-presenting greater than 7 days from symptom onset or life expectancy of less than 7 days-intravenous immunoglobulin use during current admission-receipt of convalescent plasma"}, {"type": "order", "data": "Peripheral IV Insertion", "value": "checked"}, {"type": "sentence", "data": "T;N"}, {"type": "order", "data": "Vital Signs (VS)", "value": "checked"}, {"type": "sentence", "data": "T;N, Prior to infusion, then q15min during infusion x2, then q30min until end of infusion"}, {"type": "order", "data": "Vital Signs (VS)", "value": "checked"}, {"type": "sentence", "data": "T;N, Post-infusion q30min x1 hour after infusion complete"}, {"type": "order", "data": "Notify Provider", "value": "checked"}, {"type": "sentence", "data": "T;N, Notify MRP of infusion-related reactions"}, {"type": "category", "data": "Medications"}, {"type": "order", "data": "sotrovimab", "value": "checked"}, {"type": "sentence", "data": "500 mg, IV Piggyback, Injection, Once"}, {"type": "order", "data": "acetaminophen", "value": ""}, {"type": "sentence", "data": "650 mg, PO, Caplet, As directed, PRN, 1 dose(s)"}, {"type": "sentence", "data": "650 mg, via NG tube, Liquid, As directed, PRN, 1 dose(s)"}, {"type": "sentence", "data": "650 mg, PR, Supp, As directed, PRN, 1 dose(s)"}, {"type": "order", "data": "diphenhydrAMINE", "value": ""}, {"type": "sentence", "data": "50 mg, PO, Cap, As directed, PRN, 1 dose(s)"}, {"type": "sentence", "data": "50 mg, IV Push, Injection, As directed, PRN, 1 dose(s)"}, {"type": "order", "data": "dimenhyDRINATE 50 mg oral tablet", "value": ""}, {"type": "sentence", "data": "50 mg, PO, Tab, As directed, PRN, 1 dose(s)"}, {"type": "order", "data": "dimenhyDRINATE 10 mg/mL injectable solution", "value": ""}, {"type": "sentence", "data": "50 mg, IV Push, Injection, As directed, PRN, 1 dose(s)"}, {"type": "order", "data": "methylPREDNISolone 125 mg preservative-free injection", "value": ""}, {"type": "sentence", "data": "125 mg, IV Piggyback, Injection, As directed, PRN, 1 dose(s)"}]
